GB

William G Love

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William G Love. Retrieved from https://idiyas.com/inventor/william-g-love

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: William G Love: Innovator in Medicinal Chemistry

Introduction

William G Love is a notable inventor based in Great Britain, recognized for his contributions to the field of medicinal chemistry. His innovative work focuses on the use of porphyrin compounds, which have significant implications in the treatment of various microorganisms.

Latest Patents

William G Love holds a patent titled "Novel Uses Of Porphyrin Compounds." This invention provides a method for utilizing a compound of Formula (I), or its metallated derivative, in the preparation of a medicament aimed at killing or attenuating the growth of microorganisms. Notably, this method does not involve exposing the compound to a photodynamic therapy light source or a sonodynamic therapy ultrasound source. The microorganisms targeted by this invention include bacteria, mycoplasmas, yeasts, fungi, and viruses.

Career Highlights

William G Love is currently associated with Destiny Pharma Limited, where he continues to advance his research in medicinal applications. His work is pivotal in developing new therapeutic strategies that leverage the unique properties of porphyrin compounds.

Collaborations

Some of his notable coworkers include William Rhys-Williams and Derek Brundish, who contribute to the innovative environment at Destiny Pharma Limited.

Conclusion

William G Love's work exemplifies the intersection of chemistry and medicine, showcasing the potential of porphyrin compounds in combating microbial growth. His contributions are significant in the ongoing quest for effective treatments in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…